The most common side effects of GLP-1 medications are gastrointestinal in nature: nausea, vomiting, stomach pain, constipation or diarrhea, bloating, and heartburn
With the antioxidant defenses recovering, the formula utilizes Coenzyme Q10 (CoQ10) to directly stimulate the Electron Transport Chain
An exploratory assessment of the proportion of subjects achieving at least 5% weight loss after 28 days demonstrated that up to 57% of VK2735-treated subjects achieved 5% weight loss, compared with 0% for placebo
Hepatic outcomes should be reevaluated periodically, typically every 612 months, but this may vary based on clinical course and treatment response
Trials 130 , 107176 (2023)
Oral GLP-1 medications represent a significant shift in weight loss treatment, offering patients a pill-based option instead of weekly injections